TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02051257 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01978548 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study NCT00001905 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study NCT00001905 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02909972 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT04407741 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT01257867 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01257867 — Safety Biomarker (SAF): BDNF
Study NCT04915794 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02506023 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00512759 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02363699 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04296825 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04296825 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT04296825 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04296825 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00119366 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT03037385 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT02194049 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02595372 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study NCT04600986 — Surrogate Endpoint (SUR): Serum luteinizing hormone
Study NCT01157026 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01822652 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT01822652 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06282627 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00587873 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02272504 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT03985423 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00154479 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01378325 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03406013 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT04342078 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05011344 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02357264 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02707055 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03556657 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03452865 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04502329 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01415505 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03431077 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00040417 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02621606 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT02435927 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02435927 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02425566 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00729963 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04419727 — Predictive Biomarker (PRD): GPER1 mRNA
Genes: GPER1; CEPR; CMKRL2; DRY12; GPER; GPR30
Study NCT04419727 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03493802 — Predictive Biomarker (PRD): NOX4 mRNA
Genes: NOX4; RENOX
Study NCT02502747 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00661817 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04516005 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00004179 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03876067 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02336451 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04054375 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04131504 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04131504 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05162534 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02348216 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02348216 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03161834 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03161834 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02417246 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02364362 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02364362 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02364362 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT04775147 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02232529 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02232529 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00564148 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04527289 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT05769140 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02977598 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01159470 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00815113 — Safety Biomarker (SAF): Interleukin 1
Study NCT03367598 — Predictive Biomarker (PRD): APOA5 mRNA
Genes: APOA5; RAP3; UNQ411/PRO773
Study NCT03209869 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01454739 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT00197795 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study NCT01177761 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01120847 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02523547 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02741765 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02741765 — Safety Biomarker (SAF): BDNF
Study NCT04548986 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00425607 — Predictive Biomarker (PRD): ZMPSTE24
Genes: FACE-1; Ste24p; STE24; HGPS; PRO1
Study NCT02357836 — Predictive Biomarker (PRD): SMO mRNA
Genes: SMO; SMOH
Study NCT02357836 — Predictive Biomarker (PRD): GLI2 mRNA
Genes: GLI2; THP
Study NCT02357836 — Predictive Biomarker (PRD): Zinc finger protein GLI1
Genes: GLI1; GLI
Study NCT02357836 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study NCT02357836 — Predictive Biomarker (PRD): Protein patched homolog 1
Genes: PTCH1; PTCH
Study NCT00018941 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02215395 — Predictive Biomarker (PRD): NES mRNA
Genes: NES; Nbla00170
Study NCT01205685 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00583466 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01597934 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT01597934 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04363632 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01981135 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01857544 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01857544 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02671188 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study NCT02693470 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00475059 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01202773 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01462994 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT01569048 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01853878 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT01181492 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01436747 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04685447 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04685447 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT04685447 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04685447 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04685447 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05862311 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03763045 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT03804606 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01865591 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04747366 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00458588 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01018108 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT00916019 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT02823379 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01101737 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03463499 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00315016 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02281162 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT03294824 — Predictive Biomarker (PRD): KLRC2 mRNA
Genes: KLRC2; NKG2C
Study NCT01485120 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00003664 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03940690 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03940690 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02461069 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00336414 — Predictive Biomarker (PRD): CYCS mRNA
Genes: CYCS; CYC
Study NCT03690427 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03690427 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03690427 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00415818 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT00415818 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03018080 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04045431 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01282515 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study NCT02380053 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01451255 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00047255 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04165499 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT04067414 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02161640 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02161640 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02161640 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02161640 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT02161640 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02161640 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study NCT02161640 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03964324 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03575676 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT00941603 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00941603 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01850537 — Predictive Biomarker (PRD): LIF mRNA
Genes: LIF; HILDA
Study NCT03352154 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT02421289 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT02560012 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT01998308 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01970033 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00891553 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04105296 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02762188 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02762188 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05078177 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00450229 — Predictive Biomarker (PRD): CYP1A1 mRNA
Genes: CYP1A1
Study NCT00987662 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01077518 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00934336 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00934336 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT01397942 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01970436 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04705506 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01907269 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01935232 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01018069 — Predictive Biomarker (PRD): XIAP mRNA
Genes: XIAP; API3; BIRC4; IAP3
Study NCT01969604 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00531089 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT01724164 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT03822442 — Predictive Biomarker (PRD): EMB mRNA
Genes: EMB
Study NCT00002847 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01575834 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00042991 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00042991 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03249870 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT02888197 — Predictive Biomarker (PRD): CD101 mRNA
Genes: CD101; EWI101; IGSF2; V7
Study NCT03032926 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04262999 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02430116 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study NCT02430116 — Predictive Biomarker (PRD): AIFM1 mRNA
Genes: AIFM1; AIF; PDCD8
Study NCT02430116 — Predictive Biomarker (PRD): APAF1 mRNA
Genes: APAF1; KIAA0413
Study NCT02430116 — Predictive Biomarker (PRD): CYCS mRNA
Genes: CYCS; CYC
Study NCT02430116 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT02430116 — Predictive Biomarker (PRD): BAG1 mRNA
Genes: BAG1; HAP
Study NCT02430116 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02430116 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study NCT02679170 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02679170 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT02679170 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT02785068 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT01029691 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03521245 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01866410 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01866410 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00512616 — Predictive Biomarker (PRD): SLC1A2 mRNA
Genes: SLC1A2; EAAT2; GLT1
Study NCT01098942 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00305630 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03226470 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03757247 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT03757247 — Predictive Biomarker (PRD): SPRED1 mRNA
Genes: SPRED1
Study NCT03180125 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00338923 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT04045392 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03123016 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03123016 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03123016 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01740401 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00742716 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT01105273 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00921557 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03073889 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00535236 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00535236 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01835665 — Predictive Biomarker (PRD): GRN mRNA
Genes: GRN
Study NCT04276259 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT02610946 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00305539 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01798875 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00551330 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT00551330 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT02230241 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03092128 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT03092128 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT03409861 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02015988 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00283504 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study NCT03444428 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03444428 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04273139 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study NCT00656292 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00656292 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00656292 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00986999 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03291444 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT03896945 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT01881308 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00407446 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT01168947 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03959761 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04648592 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04648592 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02431078 — Predictive Biomarker (PRD): ZEB1 mRNA
Genes: ZEB1; AREB6; TCF8
Study NCT01357551 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03510455 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT04371939 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT01227694 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22